✦ LIBER ✦
2.205 Design of the A to Z (Agonists to Zelapar) trial: Adding orally disintegrating selegiline to dopamine agonists in patients with Parkinson's disease experiencing complications
✍ Scribed by S. Isaacson; R. Pahwa; K.E. Lyons; G. Brunson
- Book ID
- 117752856
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 56 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.